Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.4 (
chondroitinase
)
2,039
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neuroglycan C
(
NGC
), a brain-specific transmembrane proteoglycan, is thought to bear not only chondroitin sulfate but also N- and O-linked oligosaccharides on its core protein. In this study, we isolated and purified
NGC
from rat brains at various developmental stages by immunoaffinity column chromatography or by immunoprecipitation, and examined the structural characters of its carbohydrate moiety. The chondroitin sulfate disaccharide composition of
NGC
at postnatal day 10 was significantly different from those of two secreted chondroitin sulfate proteoglycans, neurocan and phosphacan, purified from the brain at the same developmental stage; higher levels of 4-sulfate unit and E unit, a disulfated disaccharide unit, and a lower level of 6-sulfate unit. The levels of both 6-sulfate and E units decreased with a compensatory increase of 4-sulfate unit with postnatal development of the brain. Lectin-blot analysis of the
NGC
core glycoprotein prepared by
chondroitinase
digestion confirmed that
NGC
actually bore both N- and O-linked carbohydrates, and also revealed that lectin-species reactive with
NGC
did not always recognize other brain-specific proteoglycans, neurocan and phosphacan, and vice versa, even though they were isolated from the brain at the same stage. The reactivity of
NGC
with lectins and with the HNK-1 antibody markedly changed as the brain matured. These findings indicate that the structure of the carbohydrate moiety of
NGC
is developmentally regulated, and differs from those of neurocan and phosphacan. The developmentally-regulated structural change of the carbohydrates on
NGC
may be partly implicated in the modulation of neuronal cell recognition during brain development.
...
PMID:Developmental changes in the biochemical and immunological characters of the carbohydrate moiety of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan. 1511 11
Midkine is a heparin-binding growth factor that promotes cell attachment and process extension in undifferentiated bipolar CG-4 cells, an oligodendroglial precursor cell line. We found that CG-4 cells expressed a non-proteoglycan form of
neuroglycan C
, known as a part-time transmembrane proteoglycan. We demonstrated that
neuroglycan C
before or after
chondroitinase
ABC treatment bound to a midkine affinity column.
Neuroglycan C
lacking chondroitin sulfate chains was eluted with 0.5 m NaCl as a major fraction from the column. We confirmed that CG-4 cells expressed two isoforms of
neuroglycan C
, I, and III, by isolating cDNA. Among three functional domains of the extracellular part of
neuroglycan C
, the chondroitin sulfate attachment domain and acidic amino acid cluster box domain showed affinity for midkine, but the epidermal growth factor domain did not. Furthermore, cell surface
neuroglycan C
could be cross-linked with soluble midkine. Process extension on midkine-coated dishes was inhibited by either a monoclonal anti-
neuroglycan C
antibody C1 or a glutathione S-transferase-
neuroglycan C
fusion protein. Finally, stable transfectants of B104 neuroblastoma cells overexpressing
neuroglycan C
-I or
neuroglycan C
-III attached to the midkine substrate, spread well, and gave rise to cytoskeletal changes. Based on these results, we conclude that
neuroglycan C
is a novel component of midkine receptors involved in process elongation.
...
PMID:Neuroglycan C is a novel midkine receptor involved in process elongation of oligodendroglial precursor-like cells. 1690 7
Neuroglycan C
(
NGC
) is a transmembrane-type chondroitin sulfate proteoglycan that promotes neurite outgrowth. To identify the ligand of
NGC
, we applied a detergent-solubilized membrane fraction of fetal rat brains to an
NGC
-immobilized affinity column. Several proteins were eluted from the column including an 18 kDa-band protein recognized by an anti-pleiotrophin antibody. The binding of pleiotrophin (PTN) to
NGC
was confirmed by a quartz crystal microbalance method and had a Kd of 8.7 nM. PTN bound to the acidic amino acid cluster of the
NGC
extracellular domain. In addition, PTN bound to both chondroitin sulfate-bearing
NGC
and
chondroitinase
-treated
NGC
prepared from the neonatal rat brain. These results suggest that
NGC
interacts with PTN.
...
PMID:Neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, interacts with pleiotrophin, a heparin-binding growth factor. 2036 90